YU YONG (VP, Clinical Trial Operations) sold 2.8% of their position (4.19K shares) of GENELUX CORP on the open market
Open‑market sale worth $16.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/11/2025ACC: 0001493152-25-027338
Officer· VP, Clinical Trial Operations
Since Jan 2023
-4.19K
Net shares
Net seller
$16.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4.19K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.22K
Price / share
$3.36
Trade value
$10.81K
% of position
2.1%
8/21/2025
150.04K→146.82K
Common Stock
Direct
Shares
−973.00
Price / share
$5.37
Trade value
$5.22K
% of position
0.7%
11/17/2025
146.82K→145.84K
Total
Net shares
−4.19K
Net value
-$16.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2025 | S · Sale | −3.22K | $3.36 | $10.81K | 2.1% | 150.04K | 146.82K |
| Common Stock Direct | 11/17/2025 | S · Sale | −973.00 | $5.37 | $5.22K | 0.7% | 146.82K | 145.84K |
| Total | −4.19K | -$16.03K | ||||||
Derivative Transactions0
No derivative transactions reported